Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2024-04-02 Capital/Financing Update
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Update to Replacement Prospectus for Entitlement Offer 3 pages 367.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 3 April 2024 providing updates related to a previously announced Entitlement Offer and Replacement Prospectus. It discusses procedural updates, regulatory approvals, and plans to announce the results of the Entitlement Offer. The content focuses on capital raising activities, prospectus updates, and shareholder application rights. There are no financial statements or detailed financial performance data present. The document is not a full report but an update on financing activities and regulatory compliance related to capital raising. Therefore, it fits best under Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive update information rather than just a report publication notice, so it is not RPA or RNS.
2024-04-02 English
Suspension from Quotation 1 page 99.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX Compliance dated 2 April 2024. It announces the suspension from quotation of securities of several entities due to failure to lodge the relevant periodic report by the due date. The document is short (1069 characters) and serves as an official notice rather than a financial report or detailed filing. It does not contain financial data, management discussion, or detailed report content. It is an announcement related to regulatory compliance and market status, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-04-01 English
Replacement Prospectus for Renounceable Rights Issue 55 pages 1.4MB
Capital/Financing Update Classification · 100% confidence The document is titled 'REPLACEMENT ENTITLEMENT OFFER PROSPECTUS' and is a detailed prospectus for a renounceable pro rata offer of new shares and options to existing shareholders. It includes information about the offer, risk factors, legal notices, and instructions for investors. The document is a formal offer document prepared under the Corporations Act 2001 (Cth) and lodged with ASIC. It is not a financial report, earnings release, or management discussion, but a capital raising document aimed at informing shareholders and potential investors about the terms and conditions of the share offer. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document length is substantial (15,000 characters), indicating it is the full prospectus, not just an announcement or summary. Therefore, the correct classification is CAP with high confidence.
2024-04-01 English
Letter to Eligible Shareholders 4 pages 340.3KB
Capital/Financing Update Classification · 100% confidence The document is a detailed notice to shareholders regarding a renounceable entitlement offer, describing the terms of a capital raising through issuing new shares and options. It includes a timetable for the offer, instructions for shareholders on how to participate, and regulatory references such as the lodgement of a prospectus with ASIC and ASX announcements. The content focuses on fundraising activities and changes to the company's capital structure, including share issuance and options. There are no financial statements or earnings data, nor is this a report or announcement of voting results or management changes. The document is not a proxy statement, legal proceeding, or governance report. It clearly relates to a capital raising event and share issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive update on financing activities.
2024-04-01 English
OSX issues Replacement Prospectus for Entitlement Offer 3 pages 818.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 2 April 2024 regarding the issuance of a Replacement Prospectus for an Entitlement Offer by Osteopore Limited. It details the timetable for the entitlement offer, references the replacement prospectus, and provides information on how shareholders can access the prospectus. The document is relatively short (4586 characters) and primarily serves as an announcement of the issuance of the replacement prospectus rather than the prospectus document itself. There are no financial statements or detailed financial data included. Therefore, this document fits the category of a Capital/Financing Update (CAP), as it relates to a fundraising activity (entitlement offer) and the issuance of a prospectus for that purpose.
2024-04-01 English
Update - Proposed issue of securities - OSX 63 pages 1.3MB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard form used by entities listed on the Australian Securities Exchange (ASX) to announce a proposed issue of securities. It includes detailed information about the entity, the type of securities issue (such as pro rata issues, placements, bonus issues), and the timetable for the issue. The document is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital raising activities. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The document length is substantial and contains detailed information about the securities issuance, confirming it is not merely a brief announcement or a report publication announcement.
2024-04-01 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.